| September
13, 2004
Cellomics Launches 'Club
HCS' Interactive User Forum and On-line
Resource Center
Pittsburgh, PA (September 13, 2004).
-- Cellomics, Inc., the creator of
and
market leader in High Content Screening
(HCS), announced today the
launch of
Club HCS, a new on-line user forum
and information resource center.
This is
another addition to the new interactive
website launched by Cellomics
last
year.
With nearly a decade of experience
in developing automated high content
cell
analysis solutions for drug discovery
and systems biology, and the
largest
user base behind it, Cellomics now
offers an interactive user forum and
resource center for its customers
and users of high content screening
technology. "As our installed
base grows and HCS technology moves
into
mainstream use within pharmaceutical,
biotechnology, and academic
laboratories, our customers have asked
us to create on-line resources
where
they can get technical information
and share experiences with each
other,"
states Joseph Zock, Sr. Director of
HCS User Services at Cellomics.
"Last
year we developed a 4-day training
class, called HCS101, which has been
tremendously successful. We are now
expanding that class to include
access
to on-line technical resources, training
presentations and an
interactive
forum where researchers can come to
obtain valuable technical
information
and share their experiences."
"Club HCS represents another
valuable development from our HCS
Center of
Excellence that was formed late last
year. Our customers have developed
a
tremendous knowledge base in the field"
commented Daniel J. Calvo,
President
and CEO of Cellomics, "Club HCS
is a response to requests from our
customers
for an HCS Community where they can
interact with each other, get advice
on
new technologies and share experiences."
In addition to HCS101 and the
new
Club HCS on-line interactive forum
and resource center, Cellomics also
organizes user group meetings and
conferences where researchers can
share
their experiences and learn from other
scientists who are also using
HCS..
"We have had a long history of
holding User Group Conferences and
Scientific
Meetings about HCS applications. This
past January, we held a half-day
user
group meeting in conjunction with
the Cambridge Healthtech Institute's
High
Content Analysis Conference. Just
last quarter, we held a site-based
user
conference one of our key collaborative
sites, and beginning this
summer, we
have started a series of on-site workshops,
focusing on using HCS
technology
in high profile areas such as GPCRs,
apoptosis, and toxicology" added
Judy
P. Masucci, Director of Marketing
at Cellomics. "This is a reflection
of
our commitment to continue to provide
educational resources to our
customers."
About Cellomics Cellomics, Inc. is
automating drug discovery through
a unique, cell-based assay platform
that addresses the needs of Drug Discovery
and Systems Biology groups by offering
complete systems for High Content
Screening. The platform includes HCS
instrumentation (both fixed end-point
and kinetic systems), informatics,
cellular image analysis software (BioApplications),
fluorescent reagents, kits, cell lines,
and multiparametric assays. When applied
to early drug discovery, this platform
is proving to reduce the 'idea-to-discovery'
cycle time in drug discovery, while
increasing the probability of the
therapeutic success of leads as well
as enhancing throughput in systems
biology and basic research. Cellomics'
proprietary platforms, including the
ArrayScan(r) and KineticScan(r) HCS
Readers, along with BioApplications
software and High Content Informatics
(HCi(tm)) suite, are in use at multiple
sites within all of the top fifteen
pharmaceutical companies, as well
as leading pharmaceutical and biotechnology
companies and academic centers globally.
For more information about Cellomics,
visit our website at www.cellomics.com.
For further information, contact:
Judy P. Masucci, Ph.D.
Director of Marketing Cellomics, Inc.
100 Technology Drive
Pittsburgh, PA 15219
412-770-2200 x 2353
412-770-2450 (fax)
pr@cellomics.com
|
